Story thread · 2 reports / 2 sources
AC Immune reports positive phase 2 trial results for ACI-7104
investing.com · 17h · first report
The coverage
- AC Immune spikes after mid-stage trial data for Parkinson’s drug
seekingalpha.com · 16h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.